These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2701080

  • 1. Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductase.
    Carter GL, Thompson DP, Cory JG.
    Cancer Commun; 1989; 1(1):13-20. PubMed ID: 2701080
    [Abstract] [Full Text] [Related]

  • 2. Cell-cycle associated transcriptional regulation of ribonucleotide reductase in L1210 leukemia cells and drug-resistant variants.
    Johnson CE, Hughes K, Cory JG.
    Cancer Commun; 1991; 3(10-11):341-9. PubMed ID: 1760249
    [Abstract] [Full Text] [Related]

  • 3. Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase.
    Carter GL, Cory JG.
    Adv Enzyme Regul; 1989; 29():123-39. PubMed ID: 2699151
    [Abstract] [Full Text] [Related]

  • 4. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
    Cory JG, Sato A, Carter GL, Bacon PE, Montgomery JA, Brown NC.
    Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
    [Abstract] [Full Text] [Related]

  • 5. Factors affecting the mRNA levels for the non-heme iron and effector-binding subunits of ribonucleotide reductase.
    Carter GL, Cory JG.
    Adv Enzyme Regul; 1992; 32():227-40. PubMed ID: 1496919
    [Abstract] [Full Text] [Related]

  • 6. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL, Cory JG.
    Cancer Res; 1988 Oct 15; 48(20):5796-9. PubMed ID: 2844392
    [Abstract] [Full Text] [Related]

  • 7. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
    Sato A, Bacon PE, Cory JG.
    Adv Enzyme Regul; 1984 Oct 15; 22():231-41. PubMed ID: 6089512
    [Abstract] [Full Text] [Related]

  • 8. Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in culture.
    Sato A, Carter GL, Bacon PE, Cory JG.
    Adv Enzyme Regul; 1983 Oct 15; 21():259-70. PubMed ID: 6400064
    [Abstract] [Full Text] [Related]

  • 9. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG, Carter GL.
    Cancer Res; 1988 Feb 15; 48(4):839-43. PubMed ID: 3276399
    [Abstract] [Full Text] [Related]

  • 10. Changes in messenger RNA levels for the subunits of ribonucleotide reductase during the cell cycle of leukemia L1210 cells.
    Thompson DP, Carter GL, Cory JG.
    Cancer Commun; 1989 Feb 15; 1(4):253-60. PubMed ID: 2700914
    [Abstract] [Full Text] [Related]

  • 11. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory AH, Sato A, Thompson DP, Cory JG.
    Oncol Res; 1996 Feb 15; 8(10-11):449-56. PubMed ID: 9114437
    [Abstract] [Full Text] [Related]

  • 12. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
    Cory JG, Cory AH, Long SD, Carter GL, Johnson CE.
    Cancer Res; 1992 Apr 01; 52(7):2000-3. PubMed ID: 1551129
    [Abstract] [Full Text] [Related]

  • 13. Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in culture.
    Sato A, Carter GL, Bacon PE, Cory JG.
    Cancer Res; 1982 Nov 01; 42(11):4353-7. PubMed ID: 6751522
    [Abstract] [Full Text] [Related]

  • 14. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
    Moore EC, Hurlbert RB.
    Pharmacol Ther; 1985 Nov 01; 27(2):167-96. PubMed ID: 3898152
    [No Abstract] [Full Text] [Related]

  • 15. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
    Cory AH, Samano V, Robins MJ, Cory JG.
    Biochem Pharmacol; 1994 Jan 20; 47(2):365-71. PubMed ID: 8304981
    [Abstract] [Full Text] [Related]

  • 16. Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
    Cory AH, Hertel LW, Kroin JS, Cory JG.
    Oncol Res; 1993 Jan 20; 5(2):59-63. PubMed ID: 8364254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA, Nodzenski E.
    Exp Cell Res; 1988 Dec 20; 179(2):417-28. PubMed ID: 3056732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.